Arthur Wischnik
Short term quality of life with epirubicin-fluorouracil-cyclophosphamid (FEC) and sequential epirubicin/cyclophosphamid-docetaxel (EC-DOC) chemotherapy in patients with primary breast cancer - Results from the prospective multi-center randomized ADEBAR trial
Schwentner L, Janni W, Kiechle M, Härtl K, Weissenbacher T, Friedl T, Huober J, Scholz C, Wischnik A, Forstbauer H, Rack B, Eichler M, Singer S, Harbeck N, Fink V. Short term quality of life with epirubicin-fluorouracil-cyclophosphamid (FEC) and sequential epirubicin/cyclophosphamid-docetaxel (EC-DOC) chemotherapy in patients with primary breast cancer - Results from the prospective multi-center randomized ADEBAR trial. Breast 2016; 27:69-77.
Apr 4, 2016Short term quality of life with epirubicin-fluorouracil-cyclophosphamid (FEC) and sequential epirubicin/cyclophosphamid-docetaxel (EC-DOC) chemotherapy in patients with primary breast cancer - Results from the prospective multi-center randomized ADEBAR trial
Apr 4, 2016Breast 2016; 27:69-77
Schwentner Lukas, Janni Wolfgang, Kiechle Marion, Härtl Kristin, Weissenbacher Tobias, Friedl Thomas W P, Huober Jens, Scholz Christoph, Wischnik Arthur, Forstbauer Helmut, Rack Brigitte, Eichler Martin, Singer Susanne, Harbeck Nadia, Fink Visnja
A multicentric observational trial of pegylated liposomal doxorubicin for metastatic breast cancer
Huober J, Lück H, Goehler T, Gerhardt S, Wischnik A, Schmidt M, Neise M, Nusch A, Fett W, Rost A. A multicentric observational trial of pegylated liposomal doxorubicin for metastatic breast cancer. BMC cancer 2010; 10:2.
Jan 1, 2010A multicentric observational trial of pegylated liposomal doxorubicin for metastatic breast cancer
Jan 1, 2010BMC cancer 2010; 10:2
Huober Jens, Lück Hans-Joachim, Goehler Thomas, Gerhardt Steffen, Wischnik Arthur, Schmidt Marcus, Neise Michael, Nusch Arnd, Fett Werner, Rost Andreas